丹参酮ⅡA-丹酚酸B共载脂质体自溶性微针对烧烫伤大鼠瘢痕增生的抑制作用及机制OA
Tanshinone ⅡA-Salvianolic Acid B Co-Loaded Liposome Self-Dissolving Microneedles Inhibiting Scar Hyperplasia in Burn Rats and Its Mechanism
目的 探讨丹参酮ⅡA-丹酚酸B共载脂质体自溶性微针(Tanshinone ⅡA-Salvianolic acid B co-loaded liposome self-dissolving microneedles,TSA-SAB Lips@DMN)对烧烫伤大鼠瘢痕增生的抑制作用及机制.方法 采用浇注法制备TSA-SAB Lips@DMN.通过烧烫伤法复制增生性瘢痕大鼠模型,将模型复制成功的雌性SD大鼠随机分为模型组、阳性药组及TSA-SAB Lips@DMN低、中、高剂量组,每组 9 只,另外随机选取 9 只大鼠作为正常组.正常组、模型组不进行给药干预(涂抹生理盐水);阳性药组涂抹积雪苷霜软膏,积雪草总苷含量为2.5%,用药量约 4 cm2;TSA-SAB Lips@DMN低、中、高剂量组分别每日给予微针贴片,丹参酮ⅡA、丹酚酸B含量分别为[(216.01±1.96)、(371.65±4.23)μg]、[(432.02±3.92)、(743.30±8.46)μg]、[(648.03±5.88)、(1 114.95±12.69)μg],持续干预 14 d.采用ELISA法测定大鼠血清转化生长因子β1(TGF-β1)、Smad3 水平及瘢痕组织中Ⅰ型胶原蛋白(COL-Ⅰ)、Ⅲ型胶原蛋白(COL-Ⅲ)含量;HE及Masson染色法观察大鼠瘢痕组织病理变化;免疫组化法检测大鼠瘢痕组织中血管内皮生长因子(VEGF)蛋白表达水平.结果 与正常组比较,模型组大鼠皮肤组织中的成纤维细胞数量明显增多,真皮的棘层及颗粒细胞层显著增厚,细胞排列混乱,瘢痕增生指数明显升高(P<0.05),胶原纤维面密度明显增加(P<0.05),表明增生性瘢痕大鼠模型复制成功;血清TGF-β1、Smad3 水平明显升高(P<0.05);瘢痕组织中的COL-Ⅰ、COL-Ⅲ含量明显升高(P<0.05),VEGF表达水平明显升高(P<0.05).与模型组比较,各给药组大鼠的血清TGF-β1、Smad3 水平均明显降低(P<0.05),瘢痕增生指数明显降低(P<0.05),胶原纤维面密度明显降低(P<0.05),瘢痕组织中VEGF蛋白表达水平明显降低(P<0.05);阳性药组及TSA-SAB Lips@DMN中、高剂量组大鼠瘢痕组织中的COL-Ⅰ、COL-Ⅲ含量明显降低(P<0.05).结论 TSA-SAB Lips@DMN对烧烫伤大鼠皮肤增生性瘢痕具有明显抑制作用,可能与调节TGF-β/Smad 通路及VEGF蛋白表达有关.
Objective To investigate the inhibitory effect and mechanism of Tanshinone ⅡA-Salvianolic acid B co-loaded liposome self-dissolving microneedles(TSA-SAB Lips@DMN)on scar hyperplasia in burn rats.Methods TSA-SAB Lips@DMN was prepared by a casting method.A rat model of hypertrophic scar was established using a burn method.Female SD rats with successful modeling were randomly divided into the model group,positive drug group,and TSA-SAB Lips@DMN low-,medium-,and high-dose groups,with 9 rats in each group.An additional 9 rats were randomly selected as the normal group.The normal and model groups received no drug intervention(application of normal saline).The positive drug group was topically treated with asiaticoside cream(total asiaticoside content 2.5%,approximately 4 cm2 per application).The TSA-SAB Lips@DMN low-,medium-,and high-dose groups received daily microneedle patches with Tanshinone ⅡA and Salvianolic Acid B contents of[(216.01±1.96),(371.65±4.23)μg],[(432.02±3.92),(743.30±8.46)μg],and[(648.03±5.88),(1 114.95±12.69)μg],respectively,for 14 consecutive days.Serum levels of transforming growth factor-β1(TGF-β1)and Smad3,as well as the contents of type I collagen(COL-I)and type Ⅲ collagen(COL-Ⅲ)in scar tissue,were measured by ELISA.Pathological changes in rat scar tissue were observed by HE and Masson staining.The expression level of vascular endothelial growth factor(VEGF)protein in scar tissue was detected by immunohistochemistry.Results Compared with the normal group,the model group showed a significant increase in fibroblast number,marked thickening of the epidermal spinous and granular cell layers,disordered cell arrangement,a significantly increased scar hyperplasia index(P<0.05),and a significantly increased area density of collagen fibers(P<0.05),indicating successful replication of the hypertrophic scar rat model.Serum levels of TGF-β1 and Smad3 were significantly elevated(P<0.05).The contents of COL-Ⅰ and COL-Ⅲ in scar tissue were significantly increased(P<0.05),and VEGF expression was significantly upregulated(P<0.05).Compared with the model group,all treatment groups showed significantly reduced serum levels of TGF-β1 and Smad3(P<0.05),a significantly decreased scar hyperplasia index(P<0.05),a significantly reduced area density of collagen fibers(P<0.05),and significantly downregulated VEGF protein expression in scar tissue(P<0.05).The contents of COL-Ⅰ and COL-Ⅲ in scar tissue were significantly decreased in the positive drug group and the TSA-SAB Lips@DMN medium-and high-dose groups(P<0.05).Conclusion TSA-SAB Lips@DMN significantly inhibits skin hypertrophic scar formation in burn rats,which may be related to the regulation of the TGF-β/Smad pathway and VEGF protein expression.
李莹萍;程璐璐;彭睿翔;许警航;姚碧金;时军
广东药科大学中药学院,广东 广州 510006广东药科大学中药学院,广东 广州 510006广东药科大学中药学院,广东 广州 510006广东药科大学中药学院,广东 广州 510006广东康臣药业有限公司,广东 广州 510765广东药科大学中药学院,广东 广州 510006||广东省药物制剂研究与评价重点实验室,广东 广州 510006
医药卫生
丹参酮ⅡA丹酚酸B共载脂质体自溶性微针增生性瘢痕TGF-β/Smad通路血管内皮生长因子大鼠
Tanshinone IIASalvianolic acid Bco-loaded liposomeself-dissolving microneedlehypertrophic scarTGF-β/Smad pathwayvascular endothelial growth factorrats
《中药新药与临床药理》 2026 (2)
208-216,9
国家自然科学基金项目(82173982)广东省自然科学基金项目(2022A1515011382).
评论